Corvus: Q2 Earnings Snapshot

August 8, 2022 GMT

BURLINGAME, Calif. (AP) _ Corvus Pharmaceuticals Inc. (CRVS) on Monday reported a loss of $8.4 million in its second quarter.

The Burlingame, California-based company said it had a loss of 18 cents per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRVS at https://www.zacks.com/ap/CRVS